New York State Psychiatric Institute
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, New York State Psychiatric Institute sits in the top decile of US sponsors by registered trial count (#99 of 15,742 sponsors by registered trial count).
New York State Psychiatric Institute: 364 sponsored US clinical trials, 12 recruiting.
New York State Psychiatric Institute sponsors 364 registered US clinical trials on ClinicalTrials.gov, 12 of them currently recruiting, and 296 completed. 80 of these trials are in Phase 3-4 (later-stage) and 152 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 10 trials.
Top-decile sponsor footprint
New York State Psychiatric Institute ranks in the top decile of sponsors by registered trial count (#99 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
296 of 342 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
364 total, page 7 of 8
Dronabinol Treatment for Marijuana Addiction
NCT00217971
A Pilot Study Assessing Duloxetine's Efficacy in Atypical Depression
NCT00296699
Long-Duration Stimulant Treatment Study of ADHD in Young Children
NCT00257725
Are Two Antidepressants a Good Initial Treatment for Depression?
NCT00296712
Effectiveness of Group Interpersonal Psychotherapy in Treating Women With Prenatal Depression
NCT00633178
Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD)
NCT00219349
Comparison Between Marijuana Smoked in Cigarette Paper Versus Cigar Paper
NCT00374127
Effectiveness of Modafinil for Treating Fatigue in Adults With HIV/AIDS
NCT00118378
Treatment of Depression Following Multiple Brain Tests
NCT00296777
Transcranial Magnetic Stimulation (TMS) and Obsessive Compulsive Disorder (OCD)
NCT00106249
Appetite-Related Brain Activity in Women With Anorexia Nervosa
NCT00344656
Hormone Release and Stomach Disturbances in People With Binge Eating Disorder
NCT00307190
An fMRI Study of Self-regulation in Adolescents With Bulimia Nervosa
NCT00345943
Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa
NCT00304187
Treatment of Negative Symptoms of Schizophrenia With Transcranial Magnetic Stimulation (TMS)
NCT00517075
Antipsychotic Discontinuation in Alzheimer's Disease
NCT00417482
Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
NCT00218543
Prescription Opioid Effects in Abusers Versus Non-Abusers
NCT00158184
Paroxetine/Bupropion in Suicide Attempters/Ideators With Major Depression
NCT00429169
HIV/STD Safer Sex Skills Groups for Women in Drug Treatment Programs - 1
NCT00084188
Treatment of Adolescent Suicide Attempters (TASA)
NCT00080158
Levetiracetam for the Treatment of Alcohol Dependence and Anxiety
NCT00141115
Free Venlafaxine Treatment for Marijuana Addiction and Depression - 1
NCT00131456
Effectiveness of High Intensity Inpatient Versus Stepped Intensity Treatment for Anorexia Nervosa
NCT00815815
Women's Treatment for Trauma and Substance Use Disorders - 1
NCT00078156
The Effects of Memantine and Bupropion on Acute, Reinforcing, and Conditioned Effects of Cigarettes - 1
NCT00136747
Effectiveness of Atypical Antipsychotic Medication for Outpatients With Anorexia Nervosa
NCT00685334
Cholecystokinin for Reducing Binge Eating in People With Bulimia Nervosa
NCT00308776
Serotonin Transporter Concentrations in Women With a History of Anorexia Nervosa
NCT00320684
Therapeutic Cocaine Vaccine: Human Laboratory Study
NCT00965263
Effectiveness of Memantine in Treating Cocaine-Dependent Individuals - 2
NCT00134901
Improving Retention of Hispanics Receiving Antidepressant Therapy
NCT00057642
Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence
NCT00332228
Critical Time Intervention in the Transition From Hospital to Community in People With Severe Mental Illness
NCT00621465
Effect of Smoking Exposure on Smoking Relapse Following Brief Abstinence - 2
NCT00136838
Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression
NCT00296686
Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS)
NCT00018863
Enhancing the Outcome of Skills Training for People With Schizophrenia
NCT00069433
Treating Suicidal Behavior and Self-Mutilation in People With Borderline Personality Disorder
NCT00533117
Optimizing Electroconvulsive Therapy for Depression
NCT00045916
Effectiveness of Lithium and Valproate in Treating High-Risk Bipolar Disorder
NCT00563992
Cognitive Behavioral Therapy Plus Drug Treatment for Obsessive Compulsive Disorder
NCT00045903
Clinical Trials of Two Non-drug Treatments for Chronic Depression
NCT00006172
Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults
NCT00218114
Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Women With Anorexia Nervosa
NCT00288574
Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals
NCT00249483
HIV Counseling Intervention for Methadone-Maintained Patients - 2
NCT00061100
Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1
NCT00238914
Treatment of Panic Disorder: Long Term Strategies
NCT00000368
Treatment of Behavioral Symptoms in Alzheimer's Disease
NCT00009217
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 51 |
| Phase 2 | 101 |
| Phase 3 | 14 |
| Phase 4 | 66 |
Therapeutic Areas
What is open in the New York State Psychiatric Institute pipeline
12 recruiting of 364 indexed (3% open); 296 completed (81%).
Phase mix: 80 late (III/IV) vs 152 early (I/II) (early-phase heavy).
Top condition: Depression (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
New York State Psychiatric Institute: open-pipeline peers nationwide
Peers matched on 364 registered trials and 3% open enrollment, not the therapeutic-area sidebar.
New York State Psychiatric Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 364 trials (± recruiting share)
- Roswell Park Cancer Institute · 365 trials · 16% recruiting
- UNC Lineberger Comprehensive Cancer Center · 366 trials · 22% recruiting
- University of California, Irvine · 368 trials · 20% recruiting
- Northwell Health · 370 trials · 22% recruiting
Sponsors near 3% open enrollment (± trial volume)
- Biotronik · 3% recruiting · 30 trials
- Charles Drew University of Medicine and Science · 3% recruiting · 30 trials
- Kyntra Bio · 3% recruiting · 30 trials
- Halozyme Therapeutics · 3% recruiting · 31 trials
Related
What to do with this New York State Psychiatric Institute page
364 registered trials is a research-attention snapshot, not an endorsement of New York State Psychiatric Institute or any single study.
- 12 of New York State Psychiatric Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition New York State Psychiatric Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. New York State Psychiatric Institute pipeline card: 364 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.